PUBLISHER: Value Market Research | PRODUCT CODE: 1421038
PUBLISHER: Value Market Research | PRODUCT CODE: 1421038
The global demand for Drug Eluting Balloon Market is presumed to reach the market size of nearly USD 1332.69 MN by 2032 from USD 654.03 MN in 2023 with a CAGR of 8.23% under the study period 2024 - 2032.
A drug eluting balloon (DEB) is a medical device used in interventional cardiology and vascular surgery. It is designed to treat narrowed or blocked arteries by combining the benefits of balloon angioplasty with drug-delivery capabilities. The device consists of a balloon coated with an anti-restenotic drug, typically an antiproliferative agent.
The Drug eluting balloon (DEB) market is witnessing a significant growth driven by various factors. The escalating prevalence of coronary artery disease and peripheral arterial disease globally is a primary driver, creating a demand for minimally invasive treatments. DEBs, designed to prevent restenosis after balloon angioplasty, offer a targeted approach to address a common issue in arterial interventions. Technological advancements are pivotal in market expansion, with ongoing innovations in coating technologies, drug formulations, and balloon designs enhancing the efficacy and safety of DEBs. The preference for DEBs over other treatment options, such as drug-eluting stents, contributes to their adoption, providing the advantage of drug delivery without leaving a permanent implant. The growing recognition among healthcare professionals regarding the advantages of Drug-Eluting Balloons (DEBs), coupled with favorable clinical outcomes, is fostering increased acceptance of these devices in arterial interventions. Regulatory approvals and favorable reimbursement policies also play a role enhancing the accessibility and adoption of DEBs in clinical practice.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of drug eluting balloon. The growth and trends of drug eluting balloon industry provide a holistic approach to this study.
This section of the drug eluting balloon market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Drug Eluting Balloon market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drug Eluting Balloon market include Bayer AG, Medtronic, B. Braun Melsungen AG, Cook Medical, Inc., Boston Scientific Corporation, Becton, Dickson and Company, EuroCor, Terumo Corporation, Koninklijke Philips N.V. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.